| Mepha Pharma AG - Lamivudin-Mepha 150, Filmtabletten | | 60516 | | 01 | | Lamivudin-Mepha 150 | | Filmtabletten | | J05AF05 | | Lamivudine | | 05.08.2010 | | |
| | Composition | | lamivudinum 150.0 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 400, polysorbatum 80, E 172 (flavum), E 172 (nigrum), pro compresso obducto corresp. natrium 0.63 mg. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Lamivudine | 150 mg |
| | BAG: Active Agent | Dose |
|---|
| Lamivudine | 150 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Nigrum) | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Magnesii Stearas | | | | Polysorbatum 80 | | | | Pro Compresso Obducto | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 60 | 141.05 | 169.80 | A | SL | No |
|
|
